Patient Square Capital’s Enliven Therapeutics ELVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$4.93M	Sell	245,838 -8,000	-3%	-$160K	1.78%	11
2025 Q1	$5M	Buy	253,838 +29,800	+13%	+$586K	2.07%	9
2024 Q4	$5.04M	Buy	224,038 +133,466	+147%	+$3M	1.89%	8
2024 Q3	$2.31M	Buy	+90,572	New	+$2.31M	0.86%	9